MEDSCAPE SURVEY FINDS REASONS PAXLOVID IS UNDERPRESCRIBED FOR THOSE 65 AND OLDER, DESPITE ITS EFFECTIVENESS AGAINST COVID COMPLICATIONS
/PRNewswire/ -- Paxlovid (nirmatrelvir with ritonavir) has been shown in clinical studies to be a highly-effective treatment to mitigate the severity of a...